RECRUIT-TandAbs®: harnessing the immune system to kill cancer cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RECRUIT-TandAbs®: harnessing the immune system to kill cancer cells
Authors
Keywords
-
Journal
Future Oncology
Volume 8, Issue 6, Pages 687-695
Publisher
Future Medicine Ltd
Online
2012-07-06
DOI
10.2217/fon.12.54
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Monoclonal Antibodies for Cancer Treatment: The Trifunctional Antibody Catumaxomab (Removab®)
- (2012) Diane Seimetz Journal of Cancer
- Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma
- (2011) P. A. Moore et al. BLOOD
- T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
- (2011) B. E. Wahlin et al. CLINICAL CANCER RESEARCH
- DARPins and other repeat protein scaffolds: advances in engineering and applications
- (2011) Ykelien L Boersma et al. CURRENT OPINION IN BIOTECHNOLOGY
- Modulation of antibody effector function
- (2011) John R. Desjarlais et al. EXPERIMENTAL CELL RESEARCH
- Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
- (2011) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging immunotherapies targeting CD30 in Hodgkin's lymphoma
- (2010) Hans-Peter Gerber BIOCHEMICAL PHARMACOLOGY
- Bispecific Antibodies for Cancer Immunotherapy
- (2010) Dafne Müller et al. BIODRUGS
- Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion
- (2010) Syd Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- Bispecific antibodies for cancer therapy
- (2010) Patrick Chames et al. mAbs
- Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-IgTM) molecules
- (2010) Chengbin Wu et al. mAbs
- Structural and functional characterization of the trifunctional antibody catumaxomab
- (2010) Dirk Chelius et al. mAbs
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemical generation of bispecific antibodies
- (2010) V. R. Doppalapudi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adnectins: engineered target-binding protein therapeutics
- (2010) D. Lipovsek PROTEIN ENGINEERING DESIGN & SELECTION
- Engineered Proteins Pull Double Duty
- (2010) J. R. Cochran Science Translational Medicine
- Bispecific T-Cell Engaging Antibodies for Cancer Therapy
- (2009) P. A. Baeuerle et al. CANCER RESEARCH
- Hierarchical role of CD3 chains in thymocyte development
- (2009) Vibhuti P. Dave IMMUNOLOGICAL REVIEWS
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
- (2009) J. Bostrom et al. SCIENCE
- Immunosuppressive mechanisms in cancer: Consequences for the development of therapeutic vaccines
- (2009) Stefanie Gross et al. VACCINE
- Durable complete responses from therapy with combined epratuzumab and rituximab
- (2008) John P. Leonard et al. CANCER
- DARPins: A new generation of protein therapeutics
- (2008) Michael T. Stumpp et al. DRUG DISCOVERY TODAY
- Alternative binding proteins: Anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities
- (2008) Arne Skerra FEBS Journal
- Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer
- (2008) Antonino Musolino et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
- Hodgkin’s lymphoma: current treatment strategies and novel approaches
- (2008) Dennis A Eichenauer et al. Expert Review of Hematology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now